Why Melbourne?
We are one of the world’s leading Life Sciences clusters and a highly sought-after destination for global companies.
Centred around two co-located research precincts, Parkville and Clayton, the Victorian life sciences ecosystem brings together world leading research organisations, top tier universities, and hospitals to develop revolutionary treatments and new therapies.
Melbourne offers a low-risk, high-quality and competitive business environment with a rich legacy of commercial success, advanced manufacturing expertise, key R&D infrastructure, and attracting and maintaining a talented and skilled workforce. Industry expertise in biotechnology, medical technologies and pharmaceuticals is supported by a favourable regulatory and R&D environment and is consistently backed by strong government investment. With over 35% of the national dedicated Phase I facility beds in Australia – Melbourne is a national leader for early-stage trials. This includes specialist units focused on immunology, neuroscience, oncology, ophthalmology and paediatric diseases.
As a highly collaborative, globally connected Life Sciences ecosystem, Melbourne has 22 internationally recognised research institutes, and 7 major teaching hospitals that provide outstanding expertise in Neuroscience, Oncology, Genomics, Cardiovascular Health, Regenerative Medicine and Infectious Diseases. We are one of the few cities in the world to have two universities in the global top 40 biomedical rankings, with Monash University ranked among the very best in the world for pharmacy and pharmacology. This academic capability produces over 24,000 graduates in the health and sciences arena annually.
Melbourne carries out approximately one-third of Australia’s clinical trials, with over 1,924 commercial sponsored and 1,285 investigator institution sponsored trials ongoing in Victorian health services. Global companies are increasingly outsourcing Early Phase clinical trials, with 90% of Phase I clinical trials undertaken in Victoria sponsored by international firms.
We can help you do business with the U.S., Canada and Melbourne
The State Government of Victoria, Australia - through its investment attraction agency, Invest Victoria, and trade facilitation agency, Global Victoria - is responsible for attracting new investment into the state and connecting Victorian businesses to global market opportunities.
About Global Victoria
Global Victoria’s services are available for many organisations, including companies discovering exports for the first time. We also support rapidly expanding companies, where we can help amplify commercial potential in international markets.
Our trade specialists are well-connected and can:
- provide you with insights and market intelligence (including 1 on 1 advice and support) on doing business in the Americas
- facilitate connections to major buyers, partners and business leaders from the Americas
- help you understand market regulations and requirements
- identify trade missions, programs and grants to assist you on your export journey
- work with you to build your skills and knowledge about key export opportunities.
About Invest Victoria
Invest Victoria can help you do business with Melbourne and support your market entry or expansion into Victoria.
Their in-market investment team can connect you with the Melbourne life sciences ecosystem to:
- access networks of the right highly skilled talent
- identify potential clients, partners, and suppliers
- establish the right partnerships
- access research infrastructure
- identify suitable business locations
- access assistance from all levels of government.
Visit the Invest Victoria website to learn more.
Connect with us
Carolin McCaffrey
Investment and Trade Director: Biotechnology, Life Sciences, Medical R&D and Technology
One Broadway, 14th Floor
Cambridge MA 02142, USA
Sofia O'Hara
Trade Manager: Health and Life Sciences
575 Market St Ste 2080
San Francisco, CA 94105, USA
Stuart Bland
Lead Technology, Health and Sports
Level 33, 121 Exhibition Street,
Melbourne, Victoria, Australia, 3000
Tune in to our HealthTech Talks Podcast Series
Global Victoria's podcast series, HealthTech Talks demonstrates the breadth of Victoria’s expertise in the field of neuroscience, oncology, genomics, cardiovascular health, regenerative medicine, infectious diseases and clinical trials.
Tune in to hear first-hand insights from a selection of the State's Life Sciences leaders and learn how your organisation can benefit from working with Victoria.